Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine dose comparison with propofol for painless gastrointestinal endoscopy
ChiCTR2500103013Phase 4Not yet recruiting
- Sponsor
- The Second Affiliated Hospital of Nanchang University
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of oliceridine and propofol (4 arms), sponsored by The Second Affiliated Hospital of Nanchang University. Primary endpoints: Time of recovery of orientation, Number of cases of dizziness and 8 more. Planned start May 2025; status: not yet recruiting.
02
Drugs
oliceridinepropofol
Beyond the preview
Go deeper on ChiCTR2500103013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500103013.